tiprankstipranks

Michael Graves. Insider Profile

4 Followers
Michael Graves., Director at Eagle Pharmaceuticals, holds 0.00 shares in Eagle Pharmaceuticals (Ticker: EGRX), holds 56.47K shares in Par Pharmaceutical Cos. Inc. (Ticker: PRX). Most recently, Michael Graves. Bought ― shares of Eagle Pharmaceuticals on Mar 16, 2016 for an estimated value of 56.73K.
tipranks
Michael Graves.

Michael Graves.
Eagle Pharmaceuticals (EGRX)
Director

Not Ranked
Michael Graves. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

Michael Graves. does not currently own shares as a corporate insider.
A breakdown of Michael Graves.'s holdings

Insider Roles

Eagle Pharmaceuticals
(EGRX)
Director
Roles that Michael Graves. holds in companies

Most Profitable Insider Trade

Stock:
Eagle Pharmaceuticals
(EGRX)
Rating:Informative Buy
Date:Mar 16, 2016 - Mar 16, 2017
Return:+42.20%
The most profitable trade made by Michael Graves.

Michael Graves.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Eagle Pharmaceuticals
Mar 16, 2016
Director
Informative Buy
56.73K
$0.00
PRX
Par Pharmaceutical Cos. Inc.
List of latest transactions for each holding click on a transaction to see Michael Graves.'s performance on stock

Michael Graves. insider profile FAQ

What is the percentage of profitable transactions made by Michael Graves.?
The percentage of profitable transactions made by Michael Graves. is ―.
    What is the average return per transaction made by Michael Graves.?
    The average return per transaction made by Michael Graves. is ―.
      What stocks does Michael Graves. hold?
      Michael Graves. holds: EGRX, PRX stocks.
        What was Michael Graves.’s latest transaction?
        Michael Graves. latest transaction was an Informative Buy of $56.73K.
          What was Michael Graves.'s most profitable transaction?
          Michael Graves.’s most profitable transaction was an Informative Buy of EGRX stock on March 16, 2016. The return on the trade was 42.20%.
            What is Michael Graves.'s role in Eagle Pharmaceuticals?
            Michael Graves.'s role in Eagle Pharmaceuticals is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.